chr3-114036742-G-T
Position:
Variant summary
Our verdict is Uncertain significance. Variant got 0 ACMG points: 2P and 2B. PM2BP4_Moderate
The NM_020817.2(CCDC191):c.460C>A(p.Gln154Lys) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000101 in 1,588,572 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: 𝑓 0.000026 ( 0 hom., cov: 32)
Exomes 𝑓: 0.0000084 ( 0 hom. )
Consequence
CCDC191
NM_020817.2 missense
NM_020817.2 missense
Scores
2
16
Clinical Significance
Conservation
PhyloP100: 2.65
Genes affected
CCDC191 (HGNC:29272): (coiled-coil domain containing 191)
QTRT2 (HGNC:25771): (queuine tRNA-ribosyltransferase accessory subunit 2) This gene encodes a subunit of tRNA-guanine transglycosylase. tRNA-guanine transglycosylase is a heterodimeric enzyme complex that plays a critical role in tRNA modification by synthesizing the 7-deazaguanosine queuosine, which is found in tRNAs that code for asparagine, aspartic acid, histidine, and tyrosine. The encoded protein may play a role in the queuosine 5'-monophosphate salvage pathway. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, Feb 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 0 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.10811913).
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CCDC191 | NM_020817.2 | c.460C>A | p.Gln154Lys | missense_variant | 5/17 | ENST00000295878.8 | NP_065868.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CCDC191 | ENST00000295878.8 | c.460C>A | p.Gln154Lys | missense_variant | 5/17 | 1 | NM_020817.2 | ENSP00000295878 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000263 AC: 4AN: 151956Hom.: 0 Cov.: 32
GnomAD3 genomes
AF:
AC:
4
AN:
151956
Hom.:
Cov.:
32
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.0000168 AC: 4AN: 238752Hom.: 0 AF XY: 0.0000232 AC XY: 3AN XY: 129486
GnomAD3 exomes
AF:
AC:
4
AN:
238752
Hom.:
AF XY:
AC XY:
3
AN XY:
129486
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00000835 AC: 12AN: 1436616Hom.: 0 Cov.: 30 AF XY: 0.0000140 AC XY: 10AN XY: 714532
GnomAD4 exome
AF:
AC:
12
AN:
1436616
Hom.:
Cov.:
30
AF XY:
AC XY:
10
AN XY:
714532
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.0000263 AC: 4AN: 151956Hom.: 0 Cov.: 32 AF XY: 0.0000270 AC XY: 2AN XY: 74202
GnomAD4 genome
AF:
AC:
4
AN:
151956
Hom.:
Cov.:
32
AF XY:
AC XY:
2
AN XY:
74202
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Bravo
AF:
ExAC
AF:
AC:
3
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jun 29, 2023 | The c.460C>A (p.Q154K) alteration is located in exon 5 (coding exon 5) of the CCDC191 gene. This alteration results from a C to A substitution at nucleotide position 460, causing the glutamine (Q) at amino acid position 154 to be replaced by a lysine (K). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Benign
T;T;T
Eigen
Benign
Eigen_PC
Benign
FATHMM_MKL
Uncertain
D
LIST_S2
Benign
T;T;T
M_CAP
Benign
T
MetaRNN
Benign
T;T;T
MetaSVM
Benign
T
MutationTaster
Benign
D;N
PrimateAI
Benign
T
PROVEAN
Benign
N;N;D
REVEL
Benign
Sift
Benign
T;T;D
Sift4G
Benign
T;.;T
Polyphen
P;P;.
Vest4
MutPred
Gain of methylation at Q154 (P = 0.0043);.;.;
MVP
MPC
ClinPred
T
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at